Sign in
4/A

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0000950170-23-070912

Director sold 7,598 shares at $41.05 ($311,898)

From the SEC's structured data for this filing

Trades in this filing

PATOU GARY · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-14 Sale : show line 1 in the form −7,598 $41.05 $311,898 4,902 I
Open-market sales · 7,598 sh · avg $41.05 · $311,898
Loading xslF345X05/ownership.xml…